PRESS RELEASE published on 12/12/2024 at 15:00, 1 year 8 months ago Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS) Napo Pharmaceuticals presents statistically significant results of crofelemer in breast cancer patients for prophylaxis of CTD at SABCS. Study highlights impact of diarrhea in cancer treatment Napo Pharmaceuticals Crofelemer Breast Cancer CTD SABCS
PRESS RELEASE published on 12/12/2024 at 15:00, 1 year 8 months ago CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers Cambridge Isotope Laboratories, Inc. unveils benzene-d6 recovery program for OLED display manufacturers, offering cost savings, environmental benefits, and deuterium conservation Cambridge Isotope Laboratories Environmental Benefits Benzene-d6 Recovery Program OLED Displays Deuterium Conservation
PRESS RELEASE published on 12/12/2024 at 15:00, 1 year 8 months ago Golden Lake Reports Autumn Drill Program Results On Its Jewel Ridge Property In The Battle Mountain-Eureka Gold Belt, Eureka County, Nevada Golden Lake Exploration Inc. reports autumn drill program results at Jewel Ridge property in Nevada, with significant gold and silver intercepts. Proximal to North Peak Resources' Prospect Mountain property Nevada Golden Lake Exploration Inc. Jewel Ridge Property Autumn Drill Program Gold And Silver Intercepts
PRESS RELEASE published on 12/12/2024 at 14:45, 1 year 8 months ago TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc. TuHURA Biosciences, Inc. announces acquisition of Kineta, Inc. to expand late-stage pipeline with novel checkpoint inhibitor KVA12123 for cancer immunotherapy in 2025 Merger Agreement TuHURA Biosciences Cancer Immunotherapy KVA12123 Kineta Inc.
PRESS RELEASE published on 12/12/2024 at 14:40, 1 year 8 months ago EQS-Adhoc: Softing AG Revises Full-Year Guidance Softing AG revises full-year guidance. Due to weakened customer demand, sales and earnings expectations adjusted. Operating EBIT now expected between EUR 2-2.5M Operating EBIT Full-year Guidance Softing AG Revises Weakened Demand
PRESS RELEASE published on 12/12/2024 at 14:40, 1 year 8 months ago Annual financial statements 2023/2024: tick Trading Software AG confirms preliminary figures tick Trading Software AG confirms net profit increase of 42% to EUR 1,256 thousand for the financial year 2023/2024. Dividend proposal of €0.50/share. Annual General Meeting scheduled for April 2025 Financial Results Annual General Meeting Dividend Proposal Tick Trading Software AG EUR 1,256 Thousand
PRESS RELEASE published on 12/12/2024 at 14:30, 1 year 8 months ago Triton acquires security and communications technology product business from Bosch Triton Beratungsgesellschaft GmbH acquires Bosch security and communications technology product business, expected to close by first half of 2025 Acquisition Security Triton Communications Bosch
PRESS RELEASE published on 12/12/2024 at 14:30, 1 year 8 months ago Zentek Provides Update on International Opportunities Zentek Ltd. signs MOU with Al-Ramez International Group for tech innovation and commercialization in KSA and MENA. Key objectives and future plans outlined Innovation Partnership Zentek Ltd. Commercialization MoU
PRESS RELEASE published on 12/12/2024 at 14:30, 1 year 8 months ago FAVO Capital, Inc Closes $2 Million Bridge Raise Led by D. Boral Capital FAVO Capital, Inc. enters securities purchase agreements with investors to buy 8M shares of common stock at $0.25/share, aiming for $2.0M proceeds. D. Boral Capital acts as exclusive agent. Company focuses on Private Credit Sector growth and NASDAQ uplisting Private Placement Securities Purchase Agreements FAVO Capital NASDAQ Uplisting D. Boral Capital
PRESS RELEASE published on 12/12/2024 at 14:30, 1 year 8 months ago Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price Telomir Pharmaceuticals, Inc. raises $1 million in equity funding through The Starwood Trust, reinforcing financial strength. Telomir-1 shows transformative potential in addressing age-related conditions Financial Strength Telomir-1 Telomir Pharmaceuticals Age-reversal Science Equity Funding
Published on 08/21/2026 at 02:30, 3 hours 43 minutes ago PPX Mining Announces Completion of Debt Settlement
Published on 08/21/2026 at 00:00, 6 hours 13 minutes ago Apex Confirms Favourable Monazite and Bastnaesite Mineralogy at the Rift Rare Earth Project
Published on 08/20/2026 at 23:00, 7 hours 13 minutes ago EQ Inc. Reports Second Quarter 2026 Financial Results
Published on 08/20/2026 at 22:00, 8 hours 13 minutes ago Gold Terra Closes Third and Final Tranche of Its LIFE Offering for Gross Proceeds of Approximately C$10.1 M
Published on 08/20/2026 at 15:30, 14 hours 43 minutes ago Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/21/2026 at 03:05, 3 hours 7 minutes ago From Tokyo to Berlin, VMFi is Transforming the Multilingual Communication Landscape.
Published on 08/21/2026 at 03:00, 3 hours 12 minutes ago 5.096 Million Units Exported in Six Months: Beyond the Headline Figure, China is Reshaping Global Automotive Rules
Published on 08/21/2026 at 02:35, 3 hours 37 minutes ago Coway Honored at IDEA Design Awards 2026, Secures International Design 'Grand Slam'
Published on 08/20/2026 at 20:32, 9 hours 40 minutes ago EQS-Adhoc: DEAG Deutsche Entertainment Aktiengesellschaft: DEAG is planning a capital increase of EUR 10 million
Published on 08/18/2026 at 11:15, 2 days 18 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 3 days 10 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 3 days 21 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 07:30, 3 days 22 hours ago Disclosure of transactions in own shares from August 10 to August 14, 2026